Correlation Between Leading Edge and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Leading Edge and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leading Edge and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leading Edge Materials and Pfizer Inc CDR, you can compare the effects of market volatilities on Leading Edge and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leading Edge with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leading Edge and Pfizer.

Diversification Opportunities for Leading Edge and Pfizer

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Leading and Pfizer is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Leading Edge Materials and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Leading Edge is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leading Edge Materials are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Leading Edge i.e., Leading Edge and Pfizer go up and down completely randomly.

Pair Corralation between Leading Edge and Pfizer

Assuming the 90 days horizon Leading Edge Materials is expected to under-perform the Pfizer. In addition to that, Leading Edge is 2.89 times more volatile than Pfizer Inc CDR. It trades about -0.02 of its total potential returns per unit of risk. Pfizer Inc CDR is currently generating about 0.12 per unit of volatility. If you would invest  1,154  in Pfizer Inc CDR on October 16, 2024 and sell it today you would earn a total of  71.00  from holding Pfizer Inc CDR or generate 6.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Leading Edge Materials  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Leading Edge Materials 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Leading Edge Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Leading Edge and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Leading Edge and Pfizer

The main advantage of trading using opposite Leading Edge and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leading Edge position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Leading Edge Materials and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities